Stratagene to Present at the UBS Global Life Sciences Conference
September 19 2006 - 6:30AM
Business Wire
Stratagene Corporation (NASDAQ:STGN) today announced that it will
present at the UBS Global Life Sciences Conference, which will take
place at the Grand Hyatt Hotel in New York City, on Tuesday,
September 26, 2006. The presentation, which is scheduled for 8:30
AM Eastern Time, will include a review of the Company's business
strategy and historical financial results. A live audio-only
webcast of the presentation will be broadcast via the internet.
Those interested in listening to the webcast will find a link to
the webcast registration page on Stratagene's website,
www.stratagene.com. An archived replay of the presentation will
also be available approximately one hour following the live
presentation and may be accessed at www.stratagene.com. It will be
available for 90 days. About Stratagene Corporation Stratagene is a
developer, manufacturer and marketer of specialized life science
research and diagnostic products. The Company's life science
research unit supports advances in science by inventing,
manufacturing and distributing products that simplify, accelerate
and improve research. These products are used throughout the
academic, industrial and government research sectors in fields
spanning molecular biology, genomics, proteomics, drug discovery
and toxicology. The Company's diagnostic unit develops and
manufactures products for urinalysis as well as high quality
automated instrument and reagent systems that use blood samples to
test for more than 1,000 different allergies and autoimmune
disorders. In addition, by combining its expertise in diagnostics
and molecular biology, as well as its experience with FDA
regulatory procedures, the Company is pursuing opportunities to
expand its product portfolio to include molecular diagnostic kits
and instrumentation. More information is available at
www.stratagene.com.
Stratagene (NASDAQ:STGN)
Historical Stock Chart
From May 2024 to Jun 2024
Stratagene (NASDAQ:STGN)
Historical Stock Chart
From Jun 2023 to Jun 2024